cyclosporine has been researched along with Canine Diseases in 185 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 24 (12.97) | 18.2507 |
| 2000's | 60 (32.43) | 29.6817 |
| 2010's | 81 (43.78) | 24.3611 |
| 2020's | 20 (10.81) | 2.80 |
| Authors | Studies |
|---|---|
| Balicka, A; Balicki, I; Szadkowski, M; Zwolska, J | 1 |
| Bajwa, J | 1 |
| Viviano, KR | 1 |
| Bizikova, P; Herrmann, I; Holmes, J; Mamo, LB; Mohammed, JP; Murphy, KM | 1 |
| Beckmann, KM; Hetzel, U; Martini, F; Rostaher, A | 1 |
| Anderson, JG; Archer, T; Ford, KR; Kumar, TKS; Mackin, AJ; Murphy, BG; Stapleton, BL; Wills, RW | 1 |
| Austel, M; Banovic, F; Vargo, C | 1 |
| Morishita, K; Nakamura, K; Ohta, H; Sasaki, N; Sugawara-Suda, M; Takiguchi, M; Yamazaki, J | 1 |
| Harvey, R; Horton, H | 1 |
| Bradley, CW; Cain, CL; Fleischman, DA; Lowe, A; Mauldin, EA | 1 |
| Arteaga, K; Crasta, M; Leiva, M; Peña, T | 1 |
| Inden, T; Maeda, S; Naito, E; Narita, M; Taira, H; Yokota, S; Yuki, M | 1 |
| Ambrosini, Y; Rao, S; Twedt, D; Ullal, T; Webster, CRL | 1 |
| Mosca, M; Panzuti, P; Pin, D | 1 |
| Goto-Koshino, Y; Nakagawa, T; Ohno, K; Seno, T; Tani, A; Tomiyasu, H; Tsujimoto, H; Yokoyama, N | 1 |
| Lappin, MR; Sato, M; Shropshire, SB; Veir, JK | 1 |
| Bizikova, P; Herrmann, I; Levy, BJ; Linder, KE; Mamo, LB | 1 |
| Brady, SL; le Chevoir, M; Woodward, AP | 1 |
| Goggs, R | 1 |
| Kang, BT; Kang, JH; Kim, H; Kim, S; Koo, Y; Yang, MP; Yun, T | 1 |
| High, EJ; Olivry, T | 1 |
| Banovic, F; Linek, M; Olivry, T; Robson, D | 1 |
| Haarstad, AC; Heinrich, NA; McFadden, RA; Tomlinson, DJ | 1 |
| Cook, AK; Cummings, KJ; Heseltine, JC; Lidbury, JA; McAtee, BB; Willard, MD | 1 |
| Bettenay, SV; Classen, J; Dengler, B; Klinger, CJ; Mueller, RS; Rickerts, V | 1 |
| Borowski, S; Escalada, M; Mahabir, SP; Moyaert, H; Stegemann, MR; Van Brussel, L; Walters, RR | 1 |
| Sykes, JE; Yaemsiri, S | 1 |
| Cowgill, LD; Segev, G | 1 |
| Favrot, C; Ferrer, L; Huynh, K; Olivry, T; Paps, J; Widmer, G | 1 |
| Ahrens, K; Marsella, R; Santoro, D; White, AG | 1 |
| Mucha, D | 1 |
| Balicki, I; Radziejewski, K; Szadkowski, M | 1 |
| Gortel, K | 1 |
| Bhatti, SFM; Cornelis, I; De Decker, S; Gielen, I; Van Ham, L | 1 |
| Hwang, CY; Kang, JH; Kim, YB; Yoon, JH | 1 |
| Imai, A; Imanishi, I; Iyori, K; Kinoshita, M; Shirota, K | 1 |
| Brazís, P; Dalmau, A; Fuertes, E; Olivar, A; Ordeix, L; Pérez, C; Puigdemont, A; Ravera, I | 1 |
| Angus, J; Griffin, C; Keys, D; Rosenberg, A; Rosenkrantz, W | 1 |
| Burrows, AK; Siak, MK | 1 |
| Creevy, KE; Smith, JR; Wang, A | 1 |
| Bulsara, KR; Coates, JR; Edwards, GL; Eifler, DM; Kent, M; Platt, SR | 1 |
| Cho, KW; Ha, J; Jeon, JH; Jung, DI; Jung, HW; Kang, BT; Kim, NH; Lee, HC; Lee, JH; Moon, JH; Sur, JH | 1 |
| Bensignor, E; Carmichael, J; Dip, R; Letellier, I; Roberts, E; Rosenkrantz, W; Strehlau, G | 1 |
| Colombo, S; Noli, C | 1 |
| DeBoer, DJ | 1 |
| Nuttall, T; Reece, D; Roberts, E | 1 |
| Forsythe, P; Paterson, S | 1 |
| Król, M; Majchrzak, K; Motyl, T; Mucha, J; Pawłowski, KM | 1 |
| Barachetti, L; Gilger, BC; Mortellaro, CM; Rampazzo, A; Scevola, S | 1 |
| Banovic, F; Linder, KE; Olivry, T | 1 |
| Nødtvedt, A; Ziener, ML | 1 |
| Cosgrove, SB; Davis, KR; King, VL; Little, PR; Stegemann, MR | 1 |
| Herrtage, M; Knudsen, C; Skelly, B; Warland, J | 1 |
| Alkan, F; Celik, I; Erol, M; Izci, C; Sur, E | 1 |
| Bäumer, W; Olivry, T | 1 |
| Banovic, F; Jacob, M; Koch, S; Olivry, T; Robson, D | 1 |
| Blanco, B; Ginel, PJ; Mozos, E; Pérez-Aranda, M; Zafra, R | 1 |
| Adamek, Ł; Pomorski, Z; Szczepanik, M; Wilkołek, P; Zając, M | 1 |
| Banovic, F; Linder, KE; Olivry, T; Tobias, JR | 1 |
| Beccati, M; Comazzi, S; Cornegliani, L; Fanton, N; Martini, V | 1 |
| Doucette, K; Helbig, R; Panteri, A; Prost, C; Strehlau, G | 1 |
| Herrera, MA; Kass, PH; Rhoades, AC; Sykes, JE; Vernau, W | 1 |
| Birckel, P; Navarro, C; Séguy, L; Vila, M | 1 |
| Doucette, K; Linek, M; Löwenstein, C; Mueller, RS; Müller, MR; Röthig, A; Thorstensen, K | 1 |
| Affolter, VK; Outerbridge, CA; White, SD | 1 |
| Balicki, I; Radziejewski, K | 1 |
| Fujimura, M; Ishimaru, H; Nakatsuji, Y | 1 |
| Attar, M; Kass, PH; Maggs, DJ; Murphy, CJ; Park, SA; Sebbag, L | 1 |
| Cummings, FO; Rizzo, SA | 1 |
| Bagladi-Swanson, M; Meekins, JM; Rankin, AJ; Sharpe, EK | 1 |
| Catchpole, B; Gregory, SP; House, AK; Tivers, MS | 1 |
| Baxter, CG; Vogelnest, LJ | 1 |
| Gruber, A; Gumpenberger, M; Kneissl, S; Leschnik, M; Pakozdy, A; Thalhammer, JG; Tichy, A | 1 |
| Behr, S; Llabrés-Días, FJ; Radaelli, ST | 1 |
| Gasser, A; Hess, RS; Murray, SC | 1 |
| Albouy, M; Boulet, M; Carlotti, DN; Ducret, J; Jasmin, P; Machicote, G; Rème, CA | 1 |
| Goldman, C; Hauptman, J; Petersen, A; Rosser, E | 1 |
| Brown, DC; Casal, ML; Mauldin, EA; Morris, DO | 1 |
| DeBoer, DJ; Favrot, C; Jackson, HA; Mueller, RS; Nuttall, T; Olivry, T; Prélaud, P | 1 |
| Favrot, C; Linek, M; Lortz, J; Mecklenburg, L; Nett, C; Rüfenacht, S; Seewald, W | 1 |
| Rosenkrantz, WS; Roycroft, LM; Wilson, LS | 1 |
| Galgut, BI; Grondin, TM; Harkin, KR; Janardhan, KS; Wight-Carter, MT | 1 |
| Williams, DL | 2 |
| Bronsvoort, BM; Evans, H; Handel, IG; Kovalik, M; Mellanby, RJ; Thoday, KL; van den Broek, AH | 1 |
| Campbell, KL; Santoro, D | 1 |
| Kang, BT; Kim, HJ; Park, C; Park, HM; Yoo, JH | 1 |
| Jang, JI; Kim, HJ; Kim, JH; Kim, JW; Lee, SY; Lim, CY; Park, C; Park, HM; Yoo, JH | 1 |
| Taszkun, I | 1 |
| Kang, MH; Kim, D; Kim, HJ; Kim, JH; Park, HM | 1 |
| Pirie, CG; Pizzirani, S; Pumphrey, SA | 1 |
| Kovalik, M; Kozak, M; Palenik, L; Pomorska, D; Pomorski, Z; Shaw, DJ; Szczepanik, M; Taszkun, I; Thoday, KL; van den Broek, AH; Wilkolek, P | 1 |
| Kang, MH; Kim, DY; Kim, HJ; Kim, JW; Park, HM | 1 |
| de Mello Souza, CH; Headrick, J; Millis, DL; Weigel, JP | 1 |
| Bensignor, E; Cornegliani, L; Löwenstein, C; McEwan, NA; Nuttall, TJ; Rème, CA | 1 |
| Evans, H; Kovalik, M; Mellanby, RJ; Thoday, KL; van den Broek, AH | 1 |
| Kang, MH; Park, HM | 1 |
| Jung, DI; Kim, JW; Park, HM | 1 |
| Koch, SN; Peterson, AL; Rendahl, A; Torres, SM | 1 |
| Hatoya, S; Inaba, T; Kitamura, M; Nakayama, M; Nishida, H; Sugiura, K; Tanaka, H | 1 |
| Kovalik, M; Thoday, KL; van den Broek, AH | 1 |
| da Silva, EC; Dubovi, EJ; Kim, SG; Ledbetter, EC; Schwark, WS | 1 |
| Hirata, H; Honda, M; Lynch, J; Madarame, H; Maruo, T; Namikawa, K | 1 |
| Bailey, D; Balkman, C; Beaulieu, BB; Flory, A; Kiselow, M; Lewis, LD; McEntee, M; Waite, A | 1 |
| Kim, JH; Kim, JW; Lim, CY; Park, HM | 1 |
| Berry, J; Evans, H; Kovalik, M; Mellanby, RJ; Thoday, KL; van den Broek, AH | 1 |
| Palmeiro, BS | 1 |
| Carlotti, DN; Fisch, RD; Fontaine, J; Guaguère, E; Olivry, T; Prélaud, P; Steffan, J | 1 |
| Hardie, RJ; McAnulty, JE; Patricelli, AJ | 1 |
| Murphy, KM; Olivry, T; Rivierre, C | 1 |
| Alexander, D; Brovedani, F; Fisch, RD; Steffan, J | 1 |
| Burton, GG; Robson, DC | 1 |
| Doust, R; Griffiths, LG; Sullivan, M | 1 |
| Andreetta, F; Cerletti, M; Colpo, R; Cornelio, F; Cozzi, F; Croci, D; Davies, KE; Gilbert, R; Karpati, G; Mora, M; Negri, T; Pozza, O | 1 |
| Mueller, RS; Olivry, T | 1 |
| Robson, D | 1 |
| Fujino, Y; Hisasue, M; Masuda, K; Ohno, K; Tezuka, K; Tsujimoto, H | 1 |
| Afzal, KS; Ahmed, M; Goldberg, SN; Horkan, C; Kruskal, JB; Liu, Z; Weinstein, J | 1 |
| Werner, AH | 1 |
| Guaguère, E; Olivry, T; Steffan, J | 1 |
| Rosenkrantz, WS | 1 |
| Edwards, GA; Holloway, S; O'Neill, T | 1 |
| Blackwood, L; German, AJ; O'Neill, T; Stell, AJ | 1 |
| Ferrer, L; Fondati, A; Gruet, P; Horn, J; Noli, C; Steffan, J; Strehlau, G | 1 |
| Maurer, M; Rohlfs, A; Steffan, J; Strehlau, G | 1 |
| Adamo, FP; O'Brien, RT | 1 |
| Boss, C; Haemmerling, R; Hewicker-Trautwein, M; Linek, M; Mecklenburg, L | 1 |
| Gregory, SP; Hardie, RJ; Ladlow, J; Lipscomb, V; Sturgeon, C; Tomlin, J | 1 |
| Power, HT; Radowicz, SN | 1 |
| Parks, C; Seewald, W; Steffan, J | 1 |
| Bassett, R; Bryden, S; Burrows, A; Burton, G; Hill, A; Robson, D; Walker, R | 1 |
| Bacher, J; Bauer, TR; Burkholder, T; Colenda, L; Gu, YC; Hai, M; Hickstein, DD; Sokolic, RA; Starost, MF; Tuschong, LM | 1 |
| Callan, MB; Mauldin, E; Preziosi, D | 1 |
| Ackermann, M; Favrot, C; Grest, P; Nespecca, G; Olivry, T; Utiger, A; Werner, AH | 1 |
| Aherne, CM; Baker, KP; Breathnach, RM; Jones, BR; McGeady, TA; Quinn, PJ | 1 |
| Favrot, C; Mueller, R; Steffan, J | 1 |
| Noli, C; Toma, S | 1 |
| Bernsteen, L; Gregory, CR; Kyles, AE; Mehl, M | 1 |
| Kuhr, C; Little, MT; Lupu, M; Moore, PF; Storb, R; Stroup, PA; Sullivan, EW; Weigler, BJ; Westfall, TE; Zellmer, E | 1 |
| Gnirs, K | 1 |
| Barandica, L; Brazís, P; Church, MK; Clough, GF; García, F; Puigdemont, A | 1 |
| Haughland, SP; Jeffery, ND; Smith, PM | 1 |
| Balkman, CE; Beaulieu, BB; Lewis, LD; McEntee, MC; Page, RL; Rassnick, KM; Zgola, MM | 1 |
| Gregory, SP; Guitian, J; Hardie, RJ; House, AK | 1 |
| Bardagi, M; Fondevila, D; Font, A; Mascort, J | 1 |
| Griffin, A; Shipstone, MA; Swift, IM | 1 |
| Linek, M; Mueller, RS; Peters, S; Stechmann, K; Steffan, J; Thelen, A | 1 |
| Deneuche, A; Desbois, C; Fayolle, P; Hidalgo, A; Klein, A; Moissonnier, P; Scotti, S; Tessier, D; Viateau, V; Zylberstein, L | 1 |
| Obwolo, MJ; Oliveira, AM; Thoday, KL; van den Broek, AH | 1 |
| Bardagí, M; Ferrer, L; Fondati, A; Lloret, A | 1 |
| Hiraoka, H; Hisasue, M; Inokuma, H; Itamoto, K; Miyama, T; Mizuno, T; Nagashima, N; Okuda, M; Tanimoto, T; Watanabe, M | 1 |
| Adamo, PF; Adams, WM; Rylander, H | 1 |
| Allgoewer, I; Graenitz, U; Lambrou, GN; Latour, E; Ofri, R; Pena, TM; Spiess, BM | 1 |
| Eom, KD; Gu, SH; Heo, RY; Jeon, HW; Jung, DI; Kang, BT; Kim, JW; Lee, JH; Park, C; Park, HM; Sung, HJ; Woo, EJ; Yoo, JH | 1 |
| Hyun, C; Kim, WH; Kwak, HH; McAnulty, JF; Nam, HS; Woo, HM; Yoon, BI | 1 |
| Bounous, DI; Fullard, RJ; Hirsh, SG; Kaswan, RM | 1 |
| Brown, J; Kaswan, RL; Salisbury, MA | 1 |
| Read, RA | 1 |
| Williams, D | 1 |
| Boydell, P; Ellis, S | 1 |
| Barnett, KC; Clerc, B; de Haas, V; Jegou, JP; Neumann, W; Sansom, J; Schulte-Neumann, A; Weingarten, A | 1 |
| Hoey, AJ; Smitherman, P; Williams, DL | 1 |
| Andrews, J; Gilger, BC; Lairmore, MD; Wilkie, DA; Wyman, M | 1 |
| Adams, C; Ayres, SA; Mathews, KA; Riley, SM; Sukhiani, HR; Tano, CA | 1 |
| Barth, T; Mischke, R; Nolte, I | 1 |
| Asolati, M; Benedetti, E; Blanchard, J; Fontaine, M; Hewett, TA; Kirby, JP; Pollak, R; Ward, MG; Williams, R | 1 |
| Vaden, SL | 1 |
| Mathews, KA; Sukhiani, HR | 1 |
| Bounous, DI; Hirsh, SG; Kaswan, RL; Krenzer, KL | 1 |
| Cesano, A; Jeglum, KA; Santoli, D; Tran, T; Visonneau, S | 1 |
| Addeo, JV; Gao, J; Ghosn, CR; Schwalb, TA; Stern, ME | 1 |
| Köstlin, R | 1 |
| Gonzalez Alonso-Alegre, EM; Rodriguez Alvaro, A; Rollan Landeras, E | 1 |
| Borland, WW; Griffiths, LG; Sullivan, M | 1 |
| Fontaine, J; Olivry, T | 1 |
| Allgoewer, I; Brunnberg, L; Grüning, G; Hinkelbein, W; Höcht, S; Nausner, M | 1 |
| Davidson, G; Jackson, HA; Murphy, KM; Olivry, T; Rivierre, C; Sousa, CA | 1 |
| Alkan, F; Celik, I; Ceylan, C; Izci, C; Ogurtan, Z; Ozkan, Y; Sur, E | 1 |
| Mouatt, JG | 1 |
| Bryan, GM | 1 |
| Scarff, D; Williams, D | 1 |
| Davidson, MG; English, RV; Gerig, TM; Jamieson, VE; Nasisse, MP; Olivero, DK | 1 |
| Abrams, KL; Morgan, RV | 1 |
17 review(s) available for cyclosporine and Canine Diseases
| Article | Year |
|---|---|
Glucocorticoids, Cyclosporine, Azathioprine, Chlorambucil, and Mycophenolate in Dogs and Cats: Clinical Uses, Pharmacology, and Side Effects.
Topics: Animals; Azathioprine; Cat Diseases; Cats; Chlorambucil; Cyclosporine; Dog Diseases; Dogs; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids; Immunosuppressive Agents | 2022 |
Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia.
Topics: Anemia, Hemolytic, Autoimmune; Animals; Cyclosporine; Dog Diseases; Dogs; Enzyme Inhibitors; Immunosuppressive Agents; Mycophenolic Acid; Plasma Exchange | 2020 |
Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: A review.
Topics: Animals; Cyclosporine; Cytarabine; Dog Diseases; Dogs; Immunosuppressive Agents; Magnetic Resonance Imaging; Meningoencephalitis; Prednisolone; Prognosis; Treatment Outcome | 2019 |
Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.
Topics: Animals; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Immunosuppressive Agents; Safety; Treatment Outcome | 2014 |
Ciclosporin 10 years on: indications and efficacy.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Immunosuppressive Agents; Treatment Outcome; Veterinary Medicine | 2014 |
Atopic itch in dogs: pharmacology and modeling.
Topics: Animals; Cyclosporine; Disease Models, Animal; Dog Diseases; Dogs; Glucocorticoids; Histamine Antagonists; Janus Kinase 1; Pruritus | 2015 |
The use of ciclosporin A in veterinary dermatology.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunosuppressive Agents; Skin Diseases | 2012 |
Cyclosporine in veterinary dermatology.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Drug Interactions; Treatment Outcome | 2013 |
Cyclosporin: applications in small animal dermatology.
Topics: Administration, Oral; Animals; Cat Diseases; Cats; Clinical Trials as Topic; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Humans; Skin Diseases | 2003 |
Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis.
Topics: Administration, Oral; Animals; Cost-Benefit Analysis; Cyclosporine; Dermatitis, Atopic; Dermatology; Dog Diseases; Dogs; Evidence-Based Medicine; Glucocorticoids; Practice Guidelines as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Veterinary Medicine | 2003 |
Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dog Diseases; Dogs; Drug Interactions; Humans; Immunosuppressive Agents; Liver; Species Specificity | 2003 |
Cyclosporin A: a new drug in the field of canine dermatology.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Humans; Infusions, Intravenous; Randomized Controlled Trials as Topic; Rectal Fistula | 2004 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline | 2004 |
[Keratoconjunctivitis sicca (KCS) in dogs].
Topics: Animals; Anti-Bacterial Agents; Blindness; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Treatment Failure; Treatment Outcome | 2005 |
A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Safety; Severity of Illness Index; Treatment Outcome | 2006 |
Cyclosporine and tacrolimus.
Topics: Animals; Autoimmune Diseases; Cat Diseases; Cats; Cyclosporine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Eye Diseases; Glomerulonephritis; Graft Rejection; Immunosuppressive Agents; Skin Diseases; Tacrolimus; Transplantation | 1997 |
A comparative approach to topical cyclosporine therapy.
Topics: Administration, Topical; Animals; Cats; Corneal Diseases; Corneal Transplantation; Cyclosporine; Dog Diseases; Dogs; Graft Rejection; Immunosuppressive Agents; Keratoconjunctivitis Sicca | 1997 |
51 trial(s) available for cyclosporine and Canine Diseases
| Article | Year |
|---|---|
Clinical study on the application of dexamethasone and cyclosporine/dimethyl sulfoxide combination eye drops in the initial therapy of chronic superficial keratitis in dogs.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Dexamethasone; Dimethyl Sulfoxide; Dog Diseases; Dogs; Drug Combinations; Drug Therapy, Combination; Female; Free Radical Scavengers; Immunosuppressive Agents; Keratitis; Male | 2021 |
Comparison of whole blood concentrations of oral human generic modified ciclosporin capsules with microemulsified ciclosporin capsules approved for canine atopic dermatitis following a single oral administration to healthy dogs.
Topics: Administration, Oral; Animals; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Male; Veterinary Drugs | 2023 |
A double-blinded, randomized, controlled, crossover evaluation of a zinc methionine supplement as an adjunctive treatment for canine atopic dermatitis.
Topics: Animals; Biotin; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dietary Supplements; Dog Diseases; Dogs; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Essential; Female; Male; Methionine; Organometallic Compounds | 2017 |
A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.
Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Interleukins; Male | 2017 |
Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.
Topics: Animals; Antimicrobial Cationic Peptides; Caspase 14; Cyclophilins; Cyclosporine; Cytokines; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Filaggrin Proteins; Intermediate Filament Proteins; Random Allocation; Single-Blind Method; Skin; Thymic Stromal Lymphopoietin; Transforming Growth Factors; Tumor Necrosis Factor-alpha | 2018 |
Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs.
Topics: Administration, Topical; Animals; Chemistry, Pharmaceutical; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; Female; Male | 2013 |
Evaluation of azithromycin in systemic and toothpaste forms for the treatment of ciclosporin-associated gingival overgrowth in dogs.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Azithromycin; Cyclosporine; Dog Diseases; Dogs; Dosage Forms; Female; Gingival Overgrowth; Immunosuppressive Agents; Male | 2013 |
Effect of treatment with simvastatin and cyclosporine on neurotransmitter concentrations in cerebrospinal fluid after subarachnoid hemorrhage in dogs.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Female; gamma-Aminobutyric Acid; Glutamic Acid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Neurotransmitter Agents; Simvastatin; Subarachnoid Hemorrhage | 2013 |
Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Immunosuppressive Agents; Male; Prednisolone; Pruritus | 2013 |
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Male; Pruritus; Pyrimidines; Single-Blind Method; Sulfonamides; Treatment Outcome | 2015 |
The influence of non-specific anti-pruritus treatment with cyclosporine A on transepidermal water loss (TEWL) in natural atopic dermatitis in dogs.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Male; Pruritus; Water Loss, Insensible | 2015 |
Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Immunosuppressive Agents; Male; Pyrimidines; Sulfonamides | 2016 |
Comparison of the efficacy of prednisone and cyclosporine for treatment of dogs with primary immune-mediated polyarthritis.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrocentesis; Carbazoles; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Male; Prednisone; Surveys and Questionnaires; Tramadol | 2016 |
Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogs.
Topics: Animals; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Drug Compounding; Male; Random Allocation; Therapeutic Equivalency | 2016 |
Evaluation of cyclosporine-sparing effects of polyunsaturated fatty acids in the treatment of canine atopic dermatitis.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Fatty Acids, Omega-6; Female; Male | 2016 |
Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
Topics: Administration, Topical; Animals; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Male; Ophthalmic Solutions; Tacrolimus | 2016 |
Cyclosporin A Treatment in Intrinsic Canine Atopic Dermatitis (Atopic-like Dermatitis): Open Trial Study.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Immunosuppressive Agents | 2016 |
The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; Drug Administration Schedule; Female; Immunosuppressive Agents; Interferon Type I; Male; Recombinant Proteins | 2009 |
Investigation on the effects of ciclosporin (Atopica) on intradermal test reactivity and allergen-specific immunoglobulin (IgE) serology in atopic dogs.
Topics: Allergens; Animals; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; Immunoglobulin E; Immunosuppressive Agents; Intradermal Tests | 2010 |
Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.
Topics: Adalimumab; Animals; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cyclosporine; Dog Diseases; Dogs; Fatty Acids; Female; Genetic Predisposition to Disease; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male | 2010 |
A multicentre placebo-controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment.
Topics: Administration, Oral; Alopecia; Animals; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Sebaceous Gland Diseases; Sebaceous Glands; Treatment Outcome | 2010 |
Zinc-carnosine and vitamin E supplementation does not ameliorate gastrointestinal side effects associated with ciclosporin therapy of canine atopic dermatitis.
Topics: Animals; Appetite; Carnosine; Cyclosporine; Dermatitis, Atopic; Diarrhea; Dietary Supplements; Dog Diseases; Dogs; Drug Combinations; Immunosuppressive Agents; Vitamin E; Vomiting; Zinc | 2011 |
Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis.
Topics: Animals; Blood Glucose; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Drug Administration Schedule; Female; Fructosamine; Glucagon; Immunosuppressive Agents; Insulin; Male; Severity of Illness Index; Treatment Outcome | 2011 |
Sterile panniculitis in dogs: new diagnostic findings and alternative treatments.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dexamethasone; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; Panniculitis; Prednisolone; Treatment Outcome | 2011 |
The use of cyclosporine-A in dogs with chronic osteoarthritis: a pilot study.
Topics: Animals; Chronic Disease; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Osteoarthritis; Pilot Projects | 2011 |
Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
Topics: Administration, Oral; Administration, Topical; Aerosols; Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Hydrocortisone; Male; Single-Blind Method; Treatment Outcome | 2012 |
Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cyclosporine; Dermatologic Agents; Docetaxel; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Male; Skin Neoplasms; Taxoids | 2014 |
Ciclosporin therapy is associated with minimal changes in calcium metabolism in dogs with atopic dermatitis.
Topics: Animals; Calcium; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Homeostasis; Immunosuppressive Agents; Male; Parathyroid Hormone; Vitamin D | 2012 |
Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Female; Male; Pruritus; Seasons; Severity of Illness Index; Treatment Outcome | 2002 |
Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Drug Interactions; Drug Therapy, Combination; Female; Immunosuppressive Agents; Ketoconazole; Male; Perianal Glands; Rectal Fistula; Recurrence; Treatment Outcome | 2002 |
Efficacy of cyclosporine for treatment induction of canine pemphigus foliaceus.
Topics: Administration, Oral; Animals; Breeding; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Pemphigus; Pilot Projects; Severity of Illness Index; Treatment Outcome | 2003 |
Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Double-Blind Method; Drug Administration Schedule; Female; Male; Methylprednisolone; Treatment Outcome | 2003 |
Evaluation of once daily treatment with cyclosporine for anal furunculosis in dogs.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Anus Diseases; Cyclosporine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Furunculosis; Treatment Outcome | 2003 |
Remission of the clinical signs of atopic dermatitis in dogs after cessation of treatment with cyclosporin A or methylprednisolone.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Double-Blind Method; Follow-Up Studies; Methylprednisolone; Pruritus; Recurrence; Risk Factors; Severity of Illness Index; Skin; Treatment Outcome | 2004 |
Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
Topics: Administration, Oral; Animals; Capsules; Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Emulsions; Female; Immunosuppressive Agents; Male; Treatment Outcome | 2004 |
Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Male; Pruritus; Safety; Treatment Outcome | 2005 |
Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs--combined results from two veterinary dermatology referral centres.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Male; Prospective Studies; Severity of Illness Index; Treatment Outcome; Western Australia | 2004 |
Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing dogs.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cyclosporine; Docetaxel; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Male; Neoplasms; Taxoids | 2006 |
Evaluation of the effect of two dose rates of cyclosporine on the severity of perianal fistulae lesions and associated clinical signs in dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Female; Immunosuppressive Agents; Male; Perianal Glands; Preoperative Care; Prospective Studies; Rectal Fistula; Severity of Illness Index; Treatment Outcome | 2006 |
Influence of food intake on the clinical response to cyclosporin A in canine atopic dermatitis.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Eating; Germany; Immunosuppressive Agents; Severity of Illness Index; Treatment Outcome | 2006 |
Preoperative immunosuppressive therapy and surgery as a treatment for anal furunculosis.
Topics: Anal Sacs; Animals; Anus Diseases; Combined Modality Therapy; Cyclosporine; Dog Diseases; Dogs; Female; Furunculosis; Immunosuppressive Agents; Ketoconazole; Male; Preoperative Care; Recurrence; Treatment Outcome | 2006 |
Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
Topics: Administration, Topical; Animals; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Male; Ophthalmic Solutions; Tacrolimus; Treatment Outcome | 2009 |
A comparison of combination therapy (cyclosporine plus prednisolone) with sole prednisolone therapy in 7 dogs with necrotizing meningoencephalitis.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Immunosuppressive Agents; Leukoencephalitis, Acute Hemorrhagic; Male; Prednisolone | 2007 |
Treatment of canine nictitans plasmacytic conjunctivitis with 0.2 per cent cyclosporin ointment.
Topics: Animals; Cell Count; Conjunctivitis; Cyclosporine; Dog Diseases; Dogs; Female; Male; Nictitating Membrane; Ointments; Plasma Cells; Treatment Outcome | 1995 |
Treatment of keratoconjunctivitis sicca in dogs with cyclosporine ophthalmic ointment: a European clinical field trial.
Topics: Animals; Conjunctiva; Corneal Edema; Cyclosporine; Dog Diseases; Dogs; Europe; Female; Hypertrophy; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Male; Ointments | 1995 |
Comparison of topical cyclosporin and dexamethasone for the treatment of chronic superficial keratitis in dogs.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chronic Disease; Cross-Over Studies; Cyclosporine; Dexamethasone; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Keratitis; Male; Time Factors; Treatment Outcome | 1995 |
Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs.
Topics: Animals; Combined Modality Therapy; Cyclosporine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Immunosuppressive Agents; Male; Perianal Glands; Rectal Fistula; Time Factors; Treatment Outcome | 1997 |
Cyclosporin as the sole treatment for anal furunculosis: preliminary results.
Topics: Animals; Anus Diseases; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Furunculosis; Treatment Outcome | 1999 |
Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Topics: Administration, Oral; Animals; California; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Double-Blind Method; Female; Male; North Carolina; Prednisolone; Prospective Studies; Pruritus; Severity of Illness Index; Treatment Outcome; Virginia | 2002 |
Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dog.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Drug Synergism; Drug Therapy, Combination; Female; Immunosuppressive Agents; Ketoconazole; Male; Perianal Glands; Prospective Studies; Rectal Fistula; Treatment Outcome | 2002 |
Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
Topics: Administration, Topical; Animals; Cyclosporine; Dog Diseases; Dogs; Double-Blind Method; Keratoconjunctivitis Sicca; Ophthalmic Solutions | 1991 |
117 other study(ies) available for cyclosporine and Canine Diseases
| Article | Year |
|---|---|
Juvenile cellulitis (juvenile sterile granulomatous dermatitis and lymphadenitis) in a 9-week-old puppy treated with prednisolone-cyclosporine combination therapy.
Topics: Animals; Cellulitis; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Lymphadenitis; Prednisolone | 2022 |
Long-term effects of ciclosporin and oclacitinib on mediators of tolerance, regulatory T-cells, IL-10 and TGF-β, in dogs with atopic dermatitis.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Immune Tolerance; Interleukin-10; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2023 |
Cyclosporine induced generalized hyperkeratosis in a dog.
Topics: Animals; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Hyperplasia; Immunosuppressive Agents; Papilloma | 2023 |
Medical Management of Canine Chronic Ulcerative Stomatitis Using Cyclosporine and Metronidazole.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Interleukin-2; Metronidazole; Prospective Studies; Stomatitis | 2023 |
Evaluation of responses to immunosuppressive therapy in dogs with suspected non-regenerative immune-mediated anaemia: 11 cases (2012-2018).
Topics: Anemia; Animals; Cyclosporine; Dog Diseases; Dogs; Hospitals, Animal; Hospitals, Teaching; Immunosuppression Therapy; Immunosuppressive Agents; Prednisolone | 2023 |
Successful treatment of perianal fistulas in two dogs with oclacitinib.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Pyrimidines; Rectal Fistula | 2023 |
Clinical and histopathological features of rostrolateral nasal alar arteriopathy of German shepherd dogs.
Topics: Animals; Arteritis; Cyclosporine; Dog Diseases; Dogs; Doxycycline; Peroxidase; Pyoderma; Retrospective Studies | 2023 |
Topical 1% cyclosporine eyedrops for the treatment of crystalline corneal dystrophy in dogs.
Topics: Animals; Corneal Dystrophies, Hereditary; Cyclosporine; Dog Diseases; Dogs; Humans; Immunosuppressive Agents; Lipids; Ophthalmic Solutions; Retrospective Studies | 2023 |
Complete remission of two canine cases with precursor-targeted immune-mediated anemia after combination therapy with prednisolone, cyclosporine, and oclacitinib.
Topics: Anemia; Animals; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Potassium Iodide; Prednisolone | 2023 |
Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs.
Topics: Alanine Transaminase; Animals; Cyclosporine; Dog Diseases; Dogs; Female; Hepatitis, Chronic; Immunosuppressive Agents; Male; Protective Agents; Remission Induction; Retrospective Studies | 2019 |
Granulomatous mural folliculitis in a dog treated with ciclosporin and methotrexate.
Topics: Alopecia; Animals; Cyclosporine; Disease Management; Dog Diseases; Dogs; Female; Folliculitis; Histological Techniques; Inflammation; Methotrexate; Skin; Skin Diseases | 2020 |
Comparison of the efficacy of cyclosporine and leflunomide in treating inflammatory colorectal polyps in miniature dachshunds.
Topics: Animals; Colonic Polyps; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Japan; Leflunomide; Male; Recurrence; Retrospective Studies; Treatment Outcome | 2020 |
Ehrlichia canis in dogs experimentally infected, treated, and then immune suppressed during the acute or subclinical phases.
Topics: Anaplasma; Anaplasmosis; Animals; Babesia; Babesiosis; Cyclosporine; Dog Diseases; Dogs; Doxycycline; Ehrlichia canis; Ehrlichiosis; Imidocarb; Immunosuppressive Agents; Prednisolone | 2020 |
Cutaneous polyautoimmunity in two unrelated dogs: pemphigus foliaceus and generalized discoid lupus erythematosus.
Topics: Administration, Cutaneous; Animals; Comorbidity; Cyclosporine; Dog Diseases; Dogs; Lupus Erythematosus, Discoid; Pemphigus; Skin | 2020 |
Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Meningoencephalitis; Prednisolone; Recurrence; Retrospective Studies | 2020 |
Combination therapy with azathioprine, cyclosporine and ketoconazole in a dog with concurrent pemphigus foliaceus and hyperadrenocorticism - Case report.
Topics: Adrenocortical Hyperfunction; Animals; Azathioprine; Cyclosporine; Dog Diseases; Dogs; Drug Combinations; Female; Immunosuppressive Agents; Ketoconazole; Pemphigus | 2020 |
The prevalence of bacterial infections during cyclosporine therapy in dogs: A critically appraised topic.
Topics: Animals; Bacterial Infections; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Prevalence | 2020 |
Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Calcineurin Inhibitors; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Lupus Erythematosus, Cutaneous; Male; Skin; Tacrolimus; Treatment Outcome | 2017 |
Opportunistic Invasive Cutaneous Fungal Infections Associated with Administration of Cyclosporine to Dogs with Immune-mediated Disease.
Topics: Animals; Autoimmune Diseases; Cohort Studies; Cyclosporine; Dermatomycoses; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; Opportunistic Infections; Retrospective Studies; Texas | 2017 |
Cutaneous alternariosis in an immunocompromised dog successfully treated with cold plasma and cessation of immunosuppressive medication.
Topics: Alternariosis; Animals; Anti-Inflammatory Agents; Antifungal Agents; Cyclosporine; Dog Diseases; Dogs; Fungicides, Industrial; Imidazoles; Immunocompromised Host; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lymphangiectasis; Male; Plasma Gases; Prednisolone | 2017 |
Successful Treatment of Disseminated Nocardiosis Caused by Nocardia veterana in a Dog.
Topics: Animals; Arthritis; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Male; Nocardia; Nocardia Infections; Prednisone; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Is ciclosporin an effective treatment for canine pemphigus foliaceus?
Topics: Animals; Clinical Trials as Topic; Cyclosporine; Dog Diseases; Dogs; Pemphigus; Prednisolone; Treatment Outcome | 2017 |
Treatment of acute kidney injury associated with cyclosporine overdose in a dog using hemodialysis and charcoal hemoperfusion.
Topics: Acute Kidney Injury; Animals; Charcoal; Cyclosporine; Dog Diseases; Dogs; Drug Overdose; Female; Hemoperfusion; Prednisone; Renal Dialysis | 2018 |
Glucocorticosteroids and ciclosporin do not significantly impact canine cutaneous microbiota.
Topics: Animals; Cyclosporine; Dermatomycoses; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Malassezia; Male; Microbiota; Papillomaviridae; Papillomavirus Infections; Prednisone; Skin | 2018 |
Topics: Animals; Antifungal Agents; Cyclosporine; Dog Diseases; Dogs; Female; Immune System Diseases; Immunosuppressive Agents; Male; Mycoses; Opportunistic Infections; Retrospective Studies | 2018 |
Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
Topics: Administration, Topical; Animals; Conjunctiva; Cornea; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Male; Metaplasia; Ophthalmic Solutions; Tacrolimus | 2018 |
An embarrassment of riches: An update on the symptomatic treatment of canine atopic dermatitis.
Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Glucocorticoids; Pyrimidines; Sulfonamides | 2018 |
Canine pyoderma gangrenosum with recurring skin lesions of unknown origin and splenic involvement.
Topics: Animals; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Female; Pancreatitis; Prednisolone; Pyoderma Gangrenosum; Skin; Skin Diseases; Spleen; Treatment Outcome; Ultrasonography | 2019 |
Clinical and histopathological presentation and successful treatment with ciclosporin for canine sarcoidosis: a case report.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Sarcoidosis; Skin Diseases | 2019 |
Cutaneous nocardiosis in two dogs receiving ciclosporin therapy for the management of canine atopic dermatitis.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Immunosuppression Therapy; Immunosuppressive Agents; Male; Nocardia Infections | 2013 |
Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
Topics: Anemia, Hemolytic, Autoimmune; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Diarrhea; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Glucocorticoids; Immunoglobulins; Immunosuppressive Agents; Male; Mycophenolic Acid; Retrospective Studies | 2013 |
Unsuccessful cyclosporine plus prednisolone therapy for autoimmune meningoencephalitis in three dogs.
Topics: Animals; Autoimmune Diseases; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Fatal Outcome; Female; Immunohistochemistry; Male; Meningoencephalitis; Prednisolone; Tomography, X-Ray Computed; Treatment Failure | 2013 |
Ciclosporin-responsive sterile pustular dermatitides in two dogs.
Topics: Animals; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; Suppuration | 2014 |
Ciclosporin in canine dermatology: a decade of comfort.
Topics: Animals; Combined Modality Therapy; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Veterinary Medicine | 2014 |
Canine mammary carcinoma cell line are resistant to chemosensitizers: verapamil and cyclosporin A.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cyclosporine; Dog Diseases; Dogs; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Verapamil; Vinblastine | 2014 |
Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
Topics: Animals; Conjunctiva; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Male; Prostheses and Implants; Retrospective Studies | 2015 |
Ciclosporin therapy for canine generalized discoid lupus erythematosus refractory to doxycycline and niacinamide.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Doxycycline; Drug Therapy, Combination; Ketoconazole; Lupus Erythematosus, Discoid; Male; Niacinamide; Treatment Failure; Treatment Outcome | 2014 |
A treatment study of canine symmetrical onychomadesis (symmetrical lupoid onychodystrophy) comparing fish oil and cyclosporine supplementation in addition to a diet rich in omega-3 fatty acids.
Topics: Animals; Cyclosporine; Diet; Dog Diseases; Dogs; Fatty Acids, Omega-3; Fish Oils; Nail Diseases; Treatment Outcome | 2014 |
Apparent resolution of canine primary hypoparathyroidism with immunosuppressive treatment.
Topics: Animals; Calcium Gluconate; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Hypocalcemia; Hypoparathyroidism; Immunosuppressive Agents; Male; Prednisolone | 2015 |
Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Topics: Administration, Topical; Animals; Biopsy; Conjunctiva; Cyclosporine; Dog Diseases; Dogs; Female; Immunity, Mucosal; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Lymphocyte Subsets; Male; Mast Cells | 2015 |
Deep pyoderma caused by Burkholderia cepacia complex associated with ciclosporin administration in dogs: a case series.
Topics: Animals; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cyclosporine; Dog Diseases; Dogs; Immunocompromised Host; Immunosuppressive Agents; Male; Pyoderma; Retrospective Studies; Skin | 2015 |
Alopecia areata universalis in a dog.
Topics: Alopecia Areata; Animals; Biopsy; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Male; Skin | 2015 |
Pathology in practice. Psoriasiform lichenoid dermatitis.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dog Diseases; Dogs; Drug Eruptions; Drug Therapy, Combination; Female; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Prednisolone | 2014 |
Lymphocyte subpopulations and Treg cells in dogs with atopic dermatitis receiving ciclosporin therapy: a prospective study.
Topics: Animals; Anti-Infective Agents; Case-Control Studies; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2016 |
Alopecia universalis in a dog with testicular neoplasia.
Topics: 14-alpha Demethylase Inhibitors; Alopecia; Animals; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Ketoconazole; Male; Testicular Neoplasms | 2016 |
Assessment of tear film osmolarity using the TearLab
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Female; Humans; Keratoconjunctivitis Sicca; Osmolar Concentration; Reproducibility of Results; Tears | 2017 |
Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs.
Topics: Adrenal Cortex Hormones; Animals; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Immunosuppressive Agents; Male; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Thrombocytopenia | 2017 |
Exophthalmos due to sterile neutrophilic dermatosis in a dog.
Topics: Abscess; Adrenal Cortex Hormones; Animals; Antifungal Agents; Cyclosporine; Dermatomycoses; Diagnosis, Differential; Dog Diseases; Dogs; Drug Therapy, Combination; Exophthalmos; Male; Tomography, X-Ray Computed | 2018 |
Interleukin-2 and interferon-gamma mRNA expression in canine anal furunculosis lesions and the effect of ciclosporin therapy.
Topics: Animals; Anus Diseases; Biopsy; Cyclosporine; Dog Diseases; Dogs; Female; Furunculosis; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Male; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Statistics, Nonparametric | 2008 |
Multifocal papular deep bacterial pyoderma in a Boxer dog caused by Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Cyclosporine; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Immunohistochemistry; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Pyoderma; Treatment Outcome | 2008 |
Improved survival time in dogs with suspected GME treated with ciclosporin.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Immunosuppressive Agents; Male; Meningoencephalitis; Survival Analysis; Time Factors; Treatment Outcome | 2009 |
Treatment of meningoencephalitis of unknown origin in a dog.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Cytarabine; Dog Diseases; Dogs; Immunosuppressive Agents; Male; Meningoencephalitis; Prednisolone; Treatment Outcome | 2009 |
Transient hyperglycaemia in a prediabetic dog treated with prednisone and cyclosporin A.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Prednisone | 2009 |
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Baths; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Glucocorticoids; Tacrolimus | 2010 |
Detection of Neospora caninum tachyzoites in cerebrospinal fluid of a dog following prednisone and cyclosporine therapy.
Topics: Animals; Brain; Central Nervous System Protozoal Infections; Coccidiosis; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Immunosuppressive Agents; Neospora; Prednisone | 2010 |
Lack of effects on lymphocyte function from chronic topical ocular cyclosporine medication: a prospective study.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Drug Administration Schedule; Instillation, Drug; Keratoconjunctivitis Sicca; Lymphocyte Activation; Lymphocytes | 2010 |
Use of ciclosporin in a dog with canine juvenile sterile granulomatous dermatitis and lymphadenitis.
Topics: Animals; Cyclosporine; Dermatitis; Dermatologic Agents; Dog Diseases; Dogs; Granuloma; Lymphadenitis | 2011 |
Combination of cyclosporin A and prednisolone for juvenile cellulitis concurrent with hindlimb paresis in 3 English cocker spaniel puppies.
Topics: Animals; Anti-Inflammatory Agents; Cellulitis; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Female; Hindlimb; Lameness, Animal; Male; Prednisolone; Treatment Outcome | 2010 |
Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog.
Topics: Adenoma; Anal Gland Neoplasms; Animals; Cyclosporine; Dog Diseases; Dogs; Hyperplasia; Immunosuppressive Agents; Male; Prostate; Prostatic Diseases; Treatment Outcome | 2010 |
The evaluation of Canine Atopic Dermatitis Extent and Severity Index (CADESI) test in dogs with atopic dermatitis (AD) treated with cyclosporine or prednisone.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; Prednisone | 2010 |
360-degree conjunctival grafting for management of diffuse keratomalacia in a dog.
Topics: Animals; Conjunctiva; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Vitamin A Deficiency | 2011 |
Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Humans; Male; Phagocytes; Pilot Projects; Prednisone; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2011 |
Long-term management of vaccine-induced refractory ischemic dermatopathy in a Miniature Pinscher puppy.
Topics: Animals; Antineoplastic Agents, Alkylating; Chlorambucil; Cyclosporine; Dog Diseases; Dogs; Drug Eruptions; Female; Immunoglobulins, Intravenous; Immunosuppressive Agents; Vaccines | 2011 |
Prednisolone is associated with an increase in serum insulin but not serum fructosamine concentrations in dogs with atopic dermatitis.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Fructosamine; Insulin; Male; Prednisolone; Treatment Outcome | 2012 |
Syndrome of inappropriate antidiuretic hormone secretion concurrent with liver disease in a dog.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Female; Hepatitis, Animal; Immunosuppressive Agents; Inappropriate ADH Syndrome; Liver Failure; Prednisolone | 2012 |
Long-term immunosuppressive therapy with cyclosporine plus prednisolone for necrotizing meningoencephalitis in a Pekingese dog.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Female; Histological Techniques; Immunosuppressive Agents; Magnetic Resonance Imaging; Meningoencephalitis; Prednisolone | 2012 |
Frequency of urinary tract infection in dogs with inflammatory skin disorders treated with ciclosporin alone or in combination with glucocorticoid therapy: a retrospective study.
Topics: Animals; Cyclosporine; Dermatitis; Dermatologic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Glucocorticoids; Male; Retrospective Studies; Urinary Tract Infections | 2012 |
Three cases of idiopathic sterile pyogranulomatous inflammation of epidural fat in Miniature Dachshunds.
Topics: Adipose Tissue; Animals; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Inflammation; Laminectomy; Male; Prednisolone | 2012 |
Frequency of spontaneous canine herpesvirus-1 reactivation and ocular viral shedding in latently infected dogs and canine herpesvirus-1 reactivation and ocular viral shedding induced by topical administration of cyclosporine and systemic administration of
Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Animals; Antibodies, Viral; Cyclosporine; DNA, Viral; Dog Diseases; Dogs; Eye Diseases; Herpesviridae Infections; Herpesvirus 1, Canid; Immunosuppressive Agents; Male; Neutralization Tests; Polymerase Chain Reaction; Virus Latency | 2012 |
Gingival overgrowth in a dog that received long-term cyclosporine for immune-mediated hemolytic anemia.
Topics: Anemia, Hemolytic; Animals; Cyclosporine; Dog Diseases; Dogs; Female; Gingival Hyperplasia; Immunosuppressive Agents | 2012 |
Clinical and magnetic resonance imaging (MRI) findings of idiopathic aplastic pancytopenia in a dog treated with cyclosporine and azathioprine.
Topics: Animals; Azathioprine; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Magnetic Resonance Imaging; Pancytopenia; Treatment Outcome | 2012 |
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Topics: Adenoviridae; Animals; CD4 Lymphocyte Count; Cyclosporine; Cytoskeletal Proteins; Dog Diseases; Dogs; Dystrophin; Female; Fibrosis; Gene Expression; Genetic Therapy; Genetic Vectors; Immunohistochemistry; Immunosuppressive Agents; Male; Membrane Proteins; Models, Animal; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Transduction, Genetic; Transgenes; Utrophin | 2003 |
Clinicopathological features and therapy of myelodysplastic syndromes in two dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Death, Sudden; Dog Diseases; Dogs; Male; Myelodysplastic Syndromes; Prednisolone | 2003 |
Image-guided percutaneous chemical and radiofrequency tumor ablation in an animal model.
Topics: Acetic Acid; Animals; Catheter Ablation; Combined Modality Therapy; Cyclosporine; Dog Diseases; Dogs; Ethanol; Female; Immunosuppressive Agents; Venereal Tumors, Veterinary | 2003 |
Psoriasiform-lichenoid-like dermatosis in three dogs treated with microemulsified cyclosporine A.
Topics: Animals; Cyclosporine; Dermatitis, Seborrheic; Dermatologic Agents; Diagnosis, Differential; Dog Diseases; Dogs; Lichen Planus; Male; Psoriasis | 2003 |
Efficacy of combined cyclosporine A and ketoconazole treatment of anal furunculosis.
Topics: Animals; Antifungal Agents; Anus Diseases; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Furunculosis; Immunosuppressive Agents; Ketoconazole; Male; Severity of Illness Index; Treatment Outcome; Victoria | 2004 |
Multicentric lymphoma in a dog after cyclosporine therapy.
Topics: Animals; Antifungal Agents; Anus Diseases; Blood Cell Count; Blood Chemical Analysis; Cyclosporine; Diagnosis, Differential; Dog Diseases; Dogs; Furunculosis; Immunosuppressive Agents; Ketoconazole; Lymphoma; Male | 2004 |
Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Fatal Outcome; Female; Granuloma; Immunosuppressive Agents; Male; Meningoencephalitis; Prognosis; Treatment Outcome | 2004 |
Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Lymphadenitis; Male; Sebaceous Glands; Severity of Illness Index; Treatment Outcome | 2005 |
Cyclosporine treatment of anal furunculosis in 26 dogs.
Topics: Animals; Anus Diseases; Cyclosporine; Dog Diseases; Dogs; Female; Furunculosis; Immunosuppressive Agents; Male; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome | 2005 |
Long-term use of cyclosporine in the treatment of canine atopic dermatitis.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Drug Administration Schedule; Female; Male; Pruritus; Retrospective Studies; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2005 |
Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Cyclosporine; Dog Diseases; Dogs; Follow-Up Studies; Immunosuppressive Agents; Leukocyte-Adhesion Deficiency Syndrome; Mycophenolic Acid; Phenotype; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome | 2005 |
Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine.
Topics: Anemia; Animals; Carcinoma, Squamous Cell; Cyclosporine; Diagnosis, Differential; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Hamartoma; Immunocompromised Host; Papillomavirus Infections; Prednisone; Skin Neoplasms | 2005 |
Evaluation of papillomaviruses associated with cyclosporine-induced hyperplastic verrucous lesions in dogs.
Topics: Animals; Cyclosporine; DNA Primers; Dog Diseases; Dogs; Immunohistochemistry; Papillomaviridae; Sequence Analysis, DNA; Warts | 2005 |
Clinical, immunological and histopathological findings in a subpopulation of dogs with pododermatitis.
Topics: Animals; Anti-Inflammatory Agents; CD4-CD8 Ratio; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Female; Foot Dermatoses; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lymphocyte Subsets; Male; Prednisolone; Pruritus; Treatment Outcome | 2005 |
Three cases of immune-mediated adnexal skin disease treated with cyclosporin.
Topics: Alopecia; Animals; Cat Diseases; Cats; Cyclosporine; Dermatologic Agents; Dog Diseases; Dogs; Female; Folliculitis; Furunculosis; Lymphadenitis; Male; Treatment Outcome | 2006 |
Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy.
Topics: Animals; Azathioprine; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Male; Nephrectomy; Postoperative Complications; Prednisolone; Prospective Studies; Quality of Life; Survival Rate; Thromboembolism; Transplantation Immunology; Transplantation, Homologous; Treatment Outcome | 2006 |
Use of multigeneration-family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T-cell lymphoma.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens; Histocompatibility Testing; Immunosuppression Therapy; Lymphoma, T-Cell; Male; Transplantation Chimera; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
Ciclosporin treatment of suspected granulomatous meningoencephalomyelitis in three dogs.
Topics: Animals; Cyclosporine; Cytokines; Dog Diseases; Dogs; Female; Follow-Up Studies; Granuloma; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Meningoencephalitis; T-Lymphocytes; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Dermal microdialysis in the dog: in vivo assessment of the effect of cyclosporin A on cutaneous histamine and prostaglandin D2 release.
Topics: Administration, Oral; Animals; Ascaris suum; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Histamine; Histamine Release; Immunosuppressive Agents; Microdialysis; Prostaglandin D2; Time Factors | 2006 |
Brain abscess in a dog immunosuppressed using cyclosporin.
Topics: Animals; Brain Abscess; Cyclosporine; Dog Diseases; Dogs; Fatal Outcome; Female; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Nocardia | 2007 |
Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Dog Diseases; Dogs; Lupus Erythematosus, Cutaneous; Male | 2006 |
Successful treatment of disseminated cutaneous phaeohyphomycosis in a dog.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Cyclosporine; Dermatomycoses; Dog Diseases; Dogs; Immunocompromised Host; Immunosuppressive Agents; Male; Prednisolone; Treatment Outcome | 2006 |
Focal metatarsal sinus tracts in a Weimaraner successfully managed with ciclosporin.
Topics: Animals; Antifungal Agents; Cutaneous Fistula; Cyclosporine; Diagnosis, Differential; Dog Diseases; Dogs; Male; Metatarsal Bones; Panniculitis | 2007 |
Neutrophilic dermatosis resembling pyoderma gangrenosum in a dog with polyarthritis.
Topics: Animals; Arthritis; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Dog Diseases; Dogs; Female; Prednisone; Pyoderma Gangrenosum; Sweet Syndrome; Treatment Outcome | 2007 |
A dog with myelodysplastic syndrome: chronic myelomonocytic leukemia.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Leukemia, Myelomonocytic, Chronic | 2007 |
Ciclosporin use in multi-drug therapy for meningoencephalomyelitis of unknown aetiology in dogs.
Topics: Adrenal Cortex Hormones; Animals; Blood Cell Count; Blood Chemical Analysis; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Immunosuppressive Agents; Ketoconazole; Meningoencephalitis; Prognosis; Safety; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
Gingival overgrowth in dogs associated with clinically relevant cyclosporine blood levels: observations in a canine renal transplantation model.
Topics: Animals; Azathioprine; Cyclosporine; Dog Diseases; Dogs; Gingival Hyperplasia; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Prednisolone | 2008 |
Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
Topics: Animals; Conjunctiva; Cornea; Cyclosporine; Dog Diseases; Dogs; Eye Proteins; Female; Immunoglobulins; Keratoconjunctivitis Sicca; Male; Peroxidase; Tears | 1995 |
Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca.
Topics: Animals; Bacteria; Cornea; Cyclosporine; Dog Diseases; Dogs; Fungi; Keratoconjunctivitis Sicca; Opportunistic Infections; Reference Values; Staphylococcus; Streptococcus | 1995 |
Chronic superficial keratitis.
Topics: Animals; Chronic Disease; Cyclosporine; Dog Diseases; Dogs; Keratitis; Steroids | 1993 |
Cyclosporin eye drops.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Legislation, Drug; Ophthalmic Solutions; United Kingdom | 1993 |
Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Topics: Administration, Topical; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Dog Diseases; Dogs; Female; Immunity, Cellular; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Lymphocyte Activation; Lymphocyte Count; Male; Ophthalmic Solutions | 1995 |
Cyclosporin treatment of perianal fistulas in dogs.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Female; Fistula; Immunosuppressive Agents; Male; Perianal Glands; Pilot Projects | 1997 |
[Cyclosporin A in aplastic anemia in dogs: first results].
Topics: Anemia, Aplastic; Animals; Bone Marrow; Cyclosporine; Dog Diseases; Dogs; Female; Humans; Immunosuppressive Agents; Ovariectomy | 1997 |
Intrasplenic hepatocyte allotransplantation in dalmation dogs with and without cyclosporine immunosuppression.
Topics: Animals; Cell Transplantation; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Liver; Metabolism, Inborn Errors; Spleen; Transplantation, Homologous; Uric Acid | 1997 |
Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine.
Topics: Administration, Topical; Animals; Conjunctiva; Cyclosporine; Dog Diseases; Dogs; Keratins; Keratoconjunctivitis Sicca; Metaplasia | 1998 |
Successful treatment of canine malignant histiocytosis with the human major histocompatibility complex nonrestricted cytotoxic T-cell line TALL-104.
Topics: Animals; Cyclosporine; Cytotoxicity, Immunologic; Dog Diseases; Dogs; Female; Histiocytic Sarcoma; Humans; Immunotherapy, Adoptive; Male; Neoplastic Cells, Circulating; Remission Induction; T-Lymphocytes, Cytotoxic | 1997 |
The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
Topics: Administration, Topical; Animals; Apoptosis; Conjunctiva; Cyclosporine; DNA; Dog Diseases; Dogs; Fas Ligand Protein; fas Receptor; Female; Immunoenzyme Techniques; Immunosuppressive Agents; In Situ Nick-End Labeling; Keratoconjunctivitis Sicca; Lacrimal Apparatus; Male; Membrane Glycoproteins; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Tumor Suppressor Protein p53 | 1998 |
[Ophthalmologic quiz. Enophthalmos and blepharospasm in a dog].
Topics: Animals; Blepharospasm; Cyclosporine; Diagnosis, Differential; Dog Diseases; Dogs; Enophthalmos; Keratoconjunctivitis; Male; Ophthalmic Solutions; Pilocarpine; Prednisolone | 1998 |
Comparison of cyclosporin A and dexamethasone in the treatment of canine nictitans plasmacytic conjunctivitis.
Topics: Animals; Biopsy; Conjunctivitis; Conjunctivitis, Bacterial; Cyclosporine; Dexamethasone; Dog Diseases; Dogs; Eyelids; Staphylococcal Infections | 1999 |
Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study.
Topics: Administration, Oral; Animals; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Immunosuppressive Agents; Pilot Projects; Pruritus | 2001 |
[Treatment of keratitis superficialis chronica of the dog with strontium 90].
Topics: Animals; Combined Modality Therapy; Cyclosporine; Dog Diseases; Dogs; Female; Keratitis; Male; Prednisolone; Radiotherapy Dosage; Strontium Radioisotopes; Treatment Outcome | 2002 |
Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
Topics: Administration, Topical; Animals; Biopsy; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Keratoconjunctivitis Sicca; Lymphocyte Count; Lymphocyte Subsets; Male; Naphthol AS D Esterase; Nictitating Membrane; Random Allocation; Tears | 2002 |
Perspective, patience, and cyclosporine.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Keratoconjunctivitis Sicca; Ophthalmic Solutions | 1992 |
Chronic superficial keratitis in German shepherd dogs.
Topics: Animals; Breeding; Cyclosporine; Dog Diseases; Dogs; Keratitis | 1992 |
Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
Topics: Administration, Topical; Animals; Breeding; Chronic Disease; Cyclosporine; Dog Diseases; Dogs; Female; Follow-Up Studies; Keratoconjunctivitis Sicca; Male; Ophthalmic Solutions; Tears; Treatment Outcome | 1991 |